Expression of cellular FLICE-inhibitory protein in human coronary arteries and in a rat vascular injury model

被引:51
作者
Imanishi, T
McBride, J
Ho, Q
O'Brien, KD
Schwartz, SM
Han, DKM
机构
[1] Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Med Cardiol, Seattle, WA 98195 USA
关键词
D O I
10.1016/S0002-9440(10)64712-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We previously isolated MACH-related inducer of toxicity (MRIT), a homolog of caspase 8, MRIT, also known as c-FLICE-inhibitory protein (c-FLIP), is an enzymatically inactive homolog of caspase 8 with homology to viral FLIP (v-FLIP). Because of this homology and resemblance to dominant negative proteins, c-FLIP is widely believed to be an antagonist to the death receptor-initiated apoptotic pathways that use caspase 8, We generated a polyclonal antibody, MAG1, and show that this antibody specifically recognizes two splice forms, long form (c-FLIPL) and short form (c-FLIPs). By in situ hybridization and immunohistochemistry, we demonstrate that c-FLIP is expressed in endothelial cells, macrophages, and smooth muscle cells (SMCs) both in human coronary arteries and in cultured cells. In an uninjured rat carotid arteries, c-FLIP protein is abundant in the vascular media. After balloon angioplasty, c-FLIP protein is rapidly down-regulated in medial SMCs for 2 weeks and regains expression by 4 weeks. In contrast, the neointima is strongly immunoreactive to c-FLIP from day 7 after the initial injury and remains strongly immunoreactive until 4 to 6 weeks, Similarly there is strong c-FLIP immunoreactivity in SMCs from nonatherosclerotic diffuse intimal thickening and in the overlying endothelial cells. In contrast, c-FLIP immunoreactivity is uneven and, often absent in SMCs within the atherosclerotic plaque, Double labeling with c-FLIP antibody and terminal deoxynucleotidyl-transferase-mediated UDP end labeling (TUNEL) in the injured rat common carotid artery show that TUNEL-positive cells in the first 2 days after injury lack detectable c-FLIP, suggested a role for caspase 8 in this form of death. In contrast, there is no correlation of c-FLIP with the spontaneous elevation in death of intima seen at 7 days after injury. For human atherosclerotic plaques, the majority of TUNEL-positive cells lack detectable c-FLIP, The expression pattern of c-FLIP and the relation between c-FLIP and TUNEL suggest a role for c-FLIP- and caspase 8-driven death in control of viability of the cells of the atherosclerotic intima.
引用
收藏
页码:125 / 137
页数:13
相关论文
共 35 条
  • [11] HAN DKM, 1995, AM J PATHOL, V147, P267
  • [12] I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis
    Hu, SM
    Vincenz, C
    Ni, J
    Gentz, R
    Dixit, VM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (28) : 17255 - 17257
  • [13] CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis
    Inohara, N
    Koseki, T
    Hu, YM
    Chen, S
    Nunez, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 10717 - 10722
  • [14] Inhibition of death receptor signals by cellular FLIP
    Irmler, M
    Thome, M
    Hahne, M
    Schneider, P
    Hofmann, B
    Steiner, V
    Bodmer, JL
    Schroter, M
    Burns, K
    Mattmann, C
    Rimoldi, D
    French, LE
    Tschopp, J
    [J]. NATURE, 1997, 388 (6638) : 190 - 195
  • [15] APOPTOSIS IN HUMAN ATHEROSCLEROSIS AND RESTENOSIS
    ISNER, JM
    KEARNEY, M
    BORTMAN, S
    PASSERI, J
    [J]. CIRCULATION, 1995, 91 (11) : 2703 - 2711
  • [16] Kockx MM, 1998, AM J PATHOL, V152, P885
  • [17] Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction
    Misao, J
    Hayakawa, Y
    Ohno, M
    Kato, S
    Fujiwara, T
    Fujiwara, H
    [J]. CIRCULATION, 1996, 94 (07) : 1506 - 1512
  • [18] THE FAS DEATH FACTOR
    NAGATA, S
    GOLSTEIN, P
    [J]. SCIENCE, 1995, 267 (5203) : 1449 - 1456
  • [19] LETHAL EFFECT OF THE ANTI-FAS ANTIBODY IN MICE
    OGASAWARA, J
    WATANABEFUKUNAGA, R
    ADACHI, M
    MATSUZAWA, A
    KASUGAI, T
    KITAMURA, Y
    ITOH, N
    SUDA, T
    NAGATA, S
    [J]. NATURE, 1993, 364 (6440) : 806 - 809
  • [20] Apoptosis in the failing human heart
    Olivetti, G
    Abbi, R
    Quaini, F
    Kajstura, J
    Cheng, W
    Nitahara, JA
    Quaini, E
    DiLoreto, C
    Beltrami, CA
    Krajewski, S
    Reed, JC
    Anversa, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) : 1131 - 1141